✦ LIBER ✦

Dose intensity of irinotecan (CPT) combined with weekly cisplatin (DDP) and etoposide (ETOP) in patients (pts) with metastatic lung cancer (LC): Phase I/II study JCOG 9507

✍ Scribed by Sekine, I; Nishiwaki, Y; Kakinuma, R; Kubota, K; Hojo, F; Matsumoto, T; Ohmatsu, H; Goto, K; Kodama, T; Eguchi, K; Shinkai, T; Tamura, T; Ohe, Y; Kunitoh, H; Yoshimura, K; Saijo, N

Book ID: 118569665
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 136 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80120-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of an intensive single do

Phase II study of an intensive single dose of irinotecan (CPT-11) and cisplatin (CDDP) every three weeks, in patients with advanced non-small cell lung cancer

✍ Dómine, M; Cardenal, F; Massuti, B; Carrato, A; Felip, E; Garrido, P; Juan, O; A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A phase II study of induction chemothera

A phase II study of induction chemotherapy (Ind CT) with CPT-11 and cisplatin followed by thoracic radiation (TRT) combined with weekly CPT-11 in patients with unresectable stage III non-small-cell lung cancer (NSCLC): A Japan Clinical Oncology (JCOG) 9706 Trial

✍ Takifuji, N; Negoro, S; Fukuoka, M; Kawahara, M; Ishizuka, N; Saijo, N; Shimoyam 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB